Heterocyclyamide-substituted imidazoles

US7919489B2 · kind B2 · utility

Assignee

• AiCuris GmbH & Co. KG · DE

Inventors

• Holger Zimmermann · Falkensee, DE
• David Brueckner · Essen, DE
• Kerstin Henninger · Wuppertal, DE
• Ulrich Rosentreter · Binnen, DE
• Martin Hendrix · Tarrytown, US
• Joerg Keldenich · Wuppertal, DE
• Dieter Lang · Velbert, DE
• Martin Radtke · Erkrath, DE
• Daniela Paulsen · Wuppertal, DE
• Armin Kern · Wuppertal, DE

Key dates

• Filing date: Aug 20, 2007
• Grant date: Apr 5, 2011
• Expiry date: Aug 12, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D401/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.